Journal article

Comparison of a therapeutic‐only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders

Abstract:: Background

Bone marrow disorders encompass a group of diseases characterised by reduced production of red cells, white cells, and platelets, or defects in their function, or both. The most common bone marrow disorder is myelodysplastic syndrome. Thrombocytopenia, a low platelet count, commonly occurs in people with bone marrow failure. Platetet transfusions are routinely used in people with thrombocytopenia secondary to bone marrow failure disorders to treat or prevent bleeding. ...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Malouf, R., Ashraf, A., Hadjinicolaou, A., Doree, C., Hopewell, S., & Estcourt, L. (2018). Comparison of a therapeutic‐only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. Cochrane Database of Systematic Reviews, 2018(5), CD012342.

MLA Style

Malouf, R., et al. “Comparison of a Therapeutic‐Only versus Prophylactic Platelet Transfusion Policy for People with Congenital or Acquired Bone Marrow Failure Disorders.” Cochrane Database of Systematic Reviews, vol. 2018, no. 5, Wiley, 2018, p. CD012342.

Chicago Style

Malouf, R, A Ashraf, A Hadjinicolaou, C Doree, S Hopewell, and L Estcourt. 2018. “Comparison of a Therapeutic‐Only versus Prophylactic Platelet Transfusion Policy for People with Congenital or Acquired Bone Marrow Failure Disorders.” Cochrane Database of Systematic Reviews 2018 (5): CD012342.
Share
Print

Access Document

Files:: Malouf_et_al, Comparison of a therapeutic only, VoR.pdf

(Preview, Version of record, pdf, 528.2KB, Terms of use)

Publisher copy:: 10.1002/14651858.CD012342.pub2

Authors

+ Malouf, R More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: Nuffield Department of Population Health; NPEU
Role:: Author

+ Ashraf, A More by this author

Role:: Author

+ Hadjinicolaou, A More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: RDM; Weatherall Insti. of Molecular Medicine
Role:: Author

+ Doree, C More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: RDM; Clinical Laboratory Sciences
Role:: Author

+ Hopewell, S More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDORMS
Sub department:: Centre for Statistics in Medicine
Role:: Author
ORCID:: 0000-0002-6881-6984

More authors...

+ NHS Blood and Transplant More from this funder

+ National Institute for Health Research More from this funder

Publisher:: Wiley
Journal:: Cochrane Database of Systematic Reviews More from this journal
Volume:: 2018
Issue:: 5
Pages:: CD012342
Publication date:: 2018-05-14
Acceptance date:: 2018-05-11
DOI:: 10.1002/14651858.CD012342.pub2
EISSN:: 1469-493X
Pmid:: 29758592

Language:: English
Keywords:: humans

platelet transfusion

myelodysplastic syndromes

adult
Pubs id:: pubs:847940
UUID:: uuid:776cef79-535c-4f45-ae3b-9252fb15d5c4
Local pid:: pubs:847940
Source identifiers:: 847940
Deposit date:: 2018-08-08

Terms of use

Copyright holder:: copyrightholder
Copyright date:: 2018
Notes:: © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP